| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 |
| filingDate |
2003-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20040106391-A |
| titleOfInvention |
Quinazoline derivative and medicine |
| abstract |
It is an object of the present invention to provide excellent antitussive agents with new mechanisms of action.n n n The present invention comprises a ginseng agent having a quinazoline derivative represented by the following formula (1) or a compound represented by a salt thereof or a pharmaceutically acceptable salt thereof as an active ingredient.n n n Formula 1n n n n n n n n In the formula, R 1 represents a hydrogen atom or alkyl. Ring Q represents a cyclohexylene group or a phenylene group. A 1 and A 2 represent a single bond or an alkylene group. E represents -NHCO- and the like. A 3 represents a single bond or a divalent saturated or unsaturated aliphatic hydrocarbon group or the like. R 3 represents an acyclic aliphatic hydrocarbon group or the like. R 4 and R 5 are the same or different and represent a hydrogen atom, alkyl or the like. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101323083-B1 |
| priorityDate |
2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |